Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
Mon Compte
No element in selection

Favoris
Établissements de santé
Contact Abonnez-vous aux actualités

0 result

Topics : Patient information and patients’ rights
Topics : Economics and public health
Type : Drugs, devices and medical acts
Type : Health technology assessment
Active substance : phosphate
Active substance : hyaluronidase
Producer : industriels

Topic

Economics and public health (1)
Plus ...
- Ethics (1)
Diagnostic and therapeutic techniques (1)
Plus ...
- Esthetics (1)
Quality of care and patient safety (1)
Plus ...

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)

inconnu (1)
industriels (1)

Français (1)

Active substance

acide ascorbique (1)
alcool (1)
aminophylline (1)
artichaut (1)
azathioprine (1)
biotine (1)
calcitonine de saumon (1)
chlore actif (1)
colchicine (1)
fructose (1)
huile de ricin (1)
hyaluronidase (1)
hydrocortisone (1)
iode (1)
mannitol (1)
minoxidil (1)
pentoxifylline (1)
phosphate (1)
piroxicam (1)
prednisolone (1)
pyridoxine (1)
riboflavine (1)
sodium (1)
thiocolchicoside (1)
zinc (1)

More filter Other Filter Icon

Other Filter Icon

Search Export

Drugs, devices and medical acts

Sorted by :Relevance

Title
Date

Follow us :

Advancing quality in the fields of health and social care services

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

eNq9WNuO2jAQfd+vQEjtWxISbrttwmoLoUXqqpRLby/IJAMJDXZqOyz06+skVGTbsEsN7gNSsJ0zY8/xmZnYt9t1VNkAZSHBTtXUa9UKYI/4IV461emkr11XbztX9gptUGFZW6/pplWteBFizKmms/ocEGb6l/v3PRDvA612rio2ma/A44/WJTyM9HeIBfcoTtdU7A0J/coaeEB8pxonPBut2IxT4UXngdDvLEYe2MZ+pDi7mjWK47aRgp2AmjCg7xFeloIClsL0EkoB8y7isCR0Vwq98GbWdbtxY9WlTIRsBIwk1IMh4sGQkk3og19uCUUMpIwsHvwx0E0EPDVSCm6svDWTAkcrtB3Bj0G503ditsu3XKtpZrtpma1GrWnWWzdSpmjhqMrJIzZh5BFpmm3TAGyId5KII675oFHwAqDipyHMQ59wzaqZN5JxGxLKUaQoYiHrPuaeIjsUfjzLDD9kcYR2+orFskeFKBLTQIVCqNtIuoMJFZoViTP7Ax8nUWT8o9fTvaIo8jgVrC5JMD8iLP2R7EF0CeawPR5ROS3k2z0XQ2CXg/1JcHkeGCbzKPRk5U4IUgKMT0eD42r3v4TiDWIwpeqU4nOIffLALq9AxYgr8j7ORLQUNKa+ObNurltmsyl9wb4Jeh3JTG5CSQyG0KaQnSM5A7wg54qNYGw51G++/heqZiUU8VAER4ooTVKTBEd/13zKboG6G5ZPlIK+dSey1PmYAN2Ns7+l0KHvHIIup9gq0oBg6nOep0adl2gdv+brOEv9Dt/FwBYv6j0u2IpJRJZCUl5Y/SVgoGm21t0NihLERTfSAzYprOrBWBAbcrwMxjkPhMRjQOLC5C7mAuQUxSYb79913cls8s69dx1vZlr1Rt20hDHxbDbNVrORPbcabbNxgfXpeK0wPp6+md11J4NPrhMHhMUB2jv/13SwE1umBIe+yDKFJcPRh960644ckRySNDAQsaLhr0P30Tk+Y/wMcT+he6q3ryUVi5bnjoDzmL0yjAAxjaWR1xdULuffHtisgtEXY/XfzH6K3TKMvcw7B6afwPYTGf9PSEcvxhOXQ7aAOgiwusZeSbGfNz958aTI9XleFZ9+fWUT7XOtwLnt7f79fRtdnhFpAmfEIa/JlFVOA/fyxdiht1Xm9vBRdlFnJutDM/lV1QMl8ydyo3T5JwKL+0In+YfFIjzysfUoMW0j/9DbubKN9CNv5+oXBgNdQw==

DQRhUBGgDCYbBJRE